Watching PHIO PHARMACEUTICALS CORP.? See every signal: funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planPHIO PHARMACEUTICALS CORP.
AI Executive Summary
AI-powered analysis of 8-K filing content
Phio Pharmaceuticals appointed Dr. R. Todd Plott, M.D. to its Board of Directors on July 20, 2026, expanding the board to six members. Dr. Plott brings 30+ years of dermatology expertise and FDA advisory experience, strengthening the company's governance and clinical credibility.
Key Takeaways
Board expanded from five to six members with appointment of Dr. R. Todd Plott, M.D.
Dr. Plott brings over 30 years of dermatology and innovation experience plus FDA advisory committee background
2 more takeaways
Filing Overview
What This Means
PHIO PHARMACEUTICALS CORP. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.